Cue Biopharma
(NASDAQ) CUE
Cue Biopharma Financials at a Glance
Market Cap
$28.60M
Revenue (TTM)
$27.47M
Net Income (TTM)
$26.60M
EPS (TTM)
$-0.31
P/E Ratio
-0.93
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Price
$0.29
Volume
285,281
Open
$0.25
Price
$0.29
Volume
285,281
Open
$0.25
Previous Close
$0.29
Daily Range
$0.21 - $0.29
52-Week Range
$0.17 - $1.03
Dividend
$0.00
Beta (Volatility)
1.41 (Average)
Price
$0.29
Volume
285,281
Open
$0.25
Previous Close
$0.29
Daily Range
$0.21 - $0.29
52-Week Range
$0.17 - $1.03
CUE News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cue Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
29
CEO
Usman Azam, MD
Website
www.cuebiopharma.comHeadquarters
Boston, MA 02139, US
CUE Financials
Key Financial Metrics (TTM)
Gross Margin
88%
Operating Margin
-97%
Net Income Margin
-97%
Return on Equity
-121%
Return on Capital
-92%
Return on Assets
-63%
Earnings Yield
-1.08%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$28.60M
Shares Outstanding
97.66M
Volume
285.28K
Short Interest
0.00%
Avg. Volume
3.56M
Financials (TTM)
Gross Profit
$23.99M
Operating Income
$26.55M
EBITDA
$23.04M
Operating Cash Flow
$21.69M
Capital Expenditure
$177.00K
Free Cash Flow
$21.86M
Cash & ST Invst.
$27.14M
Total Debt
$4.20M
Cue Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$21.94M
+1292.3%
Gross Profit
$18.74M
+1088.8%
Gross Margin
85.39%
N/A
Market Cap
$28.60M
N/A
Market Cap/Employee
$697.68K
N/A
Employees
41
N/A
Net Income
$1.58M
+116.7%
EBITDA
$3.14M
+134.0%
Quarterly Fundamentals
Net Cash
$22.94M
+58.1%
Accounts Receivable
$7.45M
+687.8%
Inventory
$0.00
N/A
Long Term Debt
$2.29M
+127.9%
Short Term Debt
$1.91M
-75.7%
Return on Assets
-63.02%
N/A
Return on Invested Capital
-92.35%
N/A
Free Cash Flow
$1.08M
+88.1%
Operating Cash Flow
$1.08M
+88.1%